On the Nifty 50, traders should remain cautious as the persistent gap openings and indecisiveness on the charts highlight the ...

DEMA. Last week, the benchmark Nifty 5o index dropped around 2.50 per cent to close below crucial 23,500-mark amid ...

AstraZeneca Pharma is a portfolio stock and buy it on dips, he said. The given target for the company's stock implies a ...

With a career spanning over two decades, Zahid brings invaluable experience from diverse industries, including Fintech, BFSI, ...

SBI Securities' Sudeep Shah has recommended two midcap and one largecap stocks from different investment horizons. In ...

Axis Securities expects Budget 2025 to continue to emphasise on capital expenditure (Capex), which could act as a trigger to ...

As part of his address on ‘Capital For Growth’ at Samvad - A Symposium on Securities Market, C S Setty, Chairman of the State ...

MUMBAI (Reuters) - India's markets regulator is pushing fund houses to popularise monthly investments as low as 250 rupees, ...

SBI Securities has a ‘buy’ recommendation on eMudhra with a target price of Rs 1,048 (+14%). Analysts have given the rating on the stock based on eMudhra’s unique business model, expanding ...